Pectoral nerve block and pecto-intercostal fascial block versus thoracic paravertebral block for postoperative analgesia in modified radical mastectomy: A randomised controlled trial

改良根治性乳房切除术后镇痛:胸肌神经阻滞和胸肌肋间筋膜阻滞与胸椎旁阻滞的比较:一项随机对照试验

阅读:1

Abstract

BACKGROUND AND AIMS: Modified radical mastectomy (MRM) is associated with persistent postoperative pain. Paravertebral block (PVB) is the gold standard for postoperative analgesia. A pecto-intercostal fascial plane (PIFB) block added to the pectoral nerve block (Pecs) may provide effective analgesia. This trial aimed to compare the analgesic efficacy of Pecs-PIFB with PVB. METHODS: Fifty American Society of Anesthesiologists (ASA) I/II patients scheduled for MRM were randomly assigned to receive either Pecs-PIFB block with 30 mL for Pecs block and 15 mL for PIFB or PVB block with 20 mL (0.2% ropivacaine). Postoperatively, intravenous (IV) morphine was administered through a patient-controlled analgesia (PCA) pump. The primary outcome was to compare the time to the first demand dose of rescue analgesic. The secondary outcomes were postoperative 24-hour opioid consumption, pain scores (30 mins and 1, 2, 4, 6, 12, and 24 h), patient satisfaction score (24 h), and block-related complications. The unpaired t-test compared quantitative normally distributed data, while the Mann-Whitney U test compared quantitative discrete data. A P value < 0.05 was considered to be statistically significant. RESULTS: Patients in the Group Pecs-PIFB had an increased median time to first demand dose: 440 [interquartile range (IQR): 360-540] versus 340 (IQR: 180-360) minutes (P = 0.019) and lower median 24-h postoperative morphine consumption: 4 (3-6) versus 6 (4-8) mg (P = 0.020). Patients in the Group Pecs-PIFB had better pain scores at 30 minutes and 1 h. CONCLUSION: Compared to thoracic PVB, the combination of Pecs and PIFB block prolonged the duration of analgesia and decreased postoperative opioid consumption in patients undergoing MRM surgeries. There was no statistical increase in complications in patients receiving this block.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。